MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest Issue
While plenty of uncertainty around sustainability remains, it is clear that medtechs and other healthcare suppliers will need to take action to stay abreast of evolving regulation and customer expectations. Sustainability is here to stay, and the pace of change is likely to accelerate due to network effects. By Ilya Trakhtenberg, Jonas Funk, Stuart Jackson, John Goddard, and Kate Boynton, L.E.K. Consulting.
2C Tech was founded by two ophthalmologists at the University of Colorado who created a new device therapy that harnesses trillions of quantum dots injected into the back of the eye to restore neural pathways lost in the course of retinal diseases such as retinitis pigmentosa. While the therapy is a device, it is delivered like a drug, and will have gross margins that look a lot more like a pharmaceutical than a device.
While plenty of uncertainty around sustainability remains, it is clear that medtechs and other healthcare suppliers will need to take action to stay abreast of evolving regulation and customer expectations. Sustainability is here to stay, and the pace of change is likely to accelerate due to network effects. By Ilya Trakhtenberg, Jonas Funk, Stuart Jackson, John Goddard, and Kate Boynton, L.E.K. Consulting.